Spexin-based galanin receptor 2 agonist improves renal injury in mice with type 2 diabetes

The spexin-based GALR2 agonist (NS200) is a novel drug, which has shown antidepressant and anxiolytic action in a recent experimental study. In this study, we investigated the effects of NS200 on renal injury in an animal model of type 2 diabetes. Eight-week-old diabetic db/db mice were administered...

Descripción completa

Detalles Bibliográficos
Autores principales: Cha, Jin Joo, Park, Boo Yeon, Yoon, Sung Gi, Park, Hye Jin, Yoo, Ji Ae, Ghee, Jung Yeon, Cha, Dae Ryong, Seong, Jae Young, Kang, Young Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543361/
https://www.ncbi.nlm.nih.gov/pubmed/37789932
http://dx.doi.org/10.1080/19768354.2023.2263067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543361/
https://www.ncbi.nlm.nih.gov/pubmed/37789932
http://dx.doi.org/10.1080/19768354.2023.2263067

Ejemplares similares